OTSUKA TO RELEASE ORAL VASOPRESSIN V2-RECEPTOR ANTAGONIST DRUG

Otsuka Pharmaceutical Co., Ltd. has announced its development of Physuline 30mg, which will be released for the first time in Japan on October 24 of this year. Physuline is an oral vasopressin V2-receptor antagonist drug that has proven effective in patients with syndrome of inappropriate antidiuretic hormone (SIADH), a condition resulting in fluid overload due to the excessive release of antidiuretic hormone. JCN Network (http://www.japancorp.net/Article.Asp?Art_ID=13546)